EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...
Cathie Wood stocks have done well in the past few months, with the ARK Innovation ETF (ARKK) soaring by 72% to $64. It has risen by 40% in the last 12 months compared to the Nasdaq 100 index that has ...
Legendary fund manager Cathie Wood isn’t typically associated with boring, dividend-paying companies. Known for picking up ...
Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback